HeartSciences Inc.
HSCS
$3.70
$0.010.27%
NASDAQ
| 07/31/2025 | 04/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -56.82% | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -56.82% | -- | |||
| Cost of Revenue | -57.89% | -- | |||
| Gross Profit | -56.00% | -- | |||
| SG&A Expenses | -11.64% | -25.75% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -2.53% | -18.84% | |||
| Operating Income | 2.41% | 19.02% | |||
| Income Before Tax | 1.88% | 17.43% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 1.88% | 17.43% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 1.88% | 17.43% | |||
| EBIT | 2.41% | 19.02% | |||
| EBITDA | 2.40% | 19.13% | |||
| EPS Basic | 19.39% | 23.97% | |||
| Normalized Basic EPS | 19.39% | 23.97% | |||
| EPS Diluted | 19.39% | 23.97% | |||
| Normalized Diluted EPS | 19.39% | 23.97% | |||
| Average Basic Shares Outstanding | 21.72% | 8.60% | |||
| Average Diluted Shares Outstanding | 21.72% | 8.60% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||